Advocacy News

Logo

The ACR is your source for advocacy news impacting your practice, patients, and the rheumatology subspecialty. In addition to staying on top of ever-changing policies and political landscapes for our members, we are often invited to give statements, provide comments, or work with lawmakers to promote new policies.

For the most up to date news regarding ACR advocacy efforts, be sure to follow @ACRheumDC on Twitter.

New Resource: Understanding the New Medicare G2211 Code

Download the ACR educational guide and frequently asked questions for the new Medicare-specific add on code G2211 which addresses the complexity inherent to office and outpatient evaluation and management services.

 

Download Guide

Quarterly Advocacy Update

Since the new Congress kicked off on January 1, the ACR advocacy team has been hard at work. Not every piece of legislation, regulatory policy, or state issue makes it into a headline, but we have collected the actions of our team over the course of 2023 into one place for ACR/ARP members to stay up to date.
Read Quarterly Advocacy Update

Advocacy Priorities

See an overview of the ACR’s Policy Priorities for the U.S. Congress, federal agencies, and state governments.

Press & Public Statements

View the latest rheumatology news, including press releases and public statements about current advocacy issues affecting ACR and ARP membership in the Press Room.

ACR@Work Newsletter

The ACR publishes a bimonthly electronic newsletter for members with the latest news and activities relating to advocacy and policy updates, practice management, insurance issues, and more. See the latest issues.

July 11, 2024 – ACR Responds to Proposed 2025 Physician Payment Rule & More

June 27, 2024 – Prior Authorization Reform Bill Reintroduced, Meet the ACR Advocacy Team & More

June 13, 2024 – Nondiscrimination Rule Reinstated; the ACR Pushes for Action on Underwater Biosimilars, G2211 Reimbursement; & More

May 9, 2024 – Payers Update Infliximab Biosimilar Reimbursement, Understanding the Noncompete Ban & More

Social Media

Be sure to follow the ACR on Facebook, X, Instagram, and LinkedIn. For advocacy specific updates, follow @ACRheumDC on Twitter. ACR often interacts with lawmakers, posts pictures, circulates articles, and more. Get engaged and join the conversation.

We use cookies on our website to improve our service to you and for security purposes. By continuing to use our site without changing your browser cookie settings, you agree to our cookie policy and the use of cookies. See ACR Policies